AstraZeneca PLC (AZN)
76.97
+0.65
(+0.85%)
USD |
NASDAQ |
May 08, 16:00
76.92
-0.05
(-0.06%)
After-Hours: 07:05
AstraZeneca Total Return Level: 220.40 for May 8, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 08, 2024 | 220.40 |
May 07, 2024 | 218.54 |
May 06, 2024 | 216.93 |
May 03, 2024 | 218.62 |
May 02, 2024 | 217.05 |
May 01, 2024 | 218.79 |
April 30, 2024 | 217.28 |
April 29, 2024 | 216.13 |
April 26, 2024 | 215.24 |
April 25, 2024 | 214.84 |
April 24, 2024 | 203.88 |
April 23, 2024 | 202.87 |
April 22, 2024 | 200.81 |
April 19, 2024 | 196.29 |
April 18, 2024 | 195.74 |
April 17, 2024 | 196.23 |
April 16, 2024 | 195.47 |
April 15, 2024 | 196.80 |
April 12, 2024 | 197.38 |
April 11, 2024 | 198.86 |
April 10, 2024 | 195.03 |
April 09, 2024 | 195.89 |
April 08, 2024 | 193.85 |
April 05, 2024 | 193.14 |
April 04, 2024 | 192.82 |
Date | Value |
---|---|
April 03, 2024 | 191.30 |
April 02, 2024 | 191.85 |
April 01, 2024 | 192.56 |
March 28, 2024 | 194.00 |
March 27, 2024 | 195.46 |
March 26, 2024 | 189.93 |
March 25, 2024 | 188.58 |
March 22, 2024 | 189.73 |
March 21, 2024 | 189.53 |
March 20, 2024 | 188.21 |
March 19, 2024 | 188.58 |
March 18, 2024 | 188.56 |
March 15, 2024 | 189.87 |
March 14, 2024 | 191.96 |
March 13, 2024 | 193.51 |
March 12, 2024 | 192.99 |
March 11, 2024 | 193.77 |
March 08, 2024 | 190.42 |
March 07, 2024 | 189.53 |
March 06, 2024 | 186.90 |
March 05, 2024 | 185.58 |
March 04, 2024 | 185.52 |
March 01, 2024 | 184.98 |
February 29, 2024 | 183.72 |
February 28, 2024 | 187.12 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
94.07
Minimum
May 13 2019
220.40
Maximum
May 08 2024
157.63
Average
156.57
Median
Dec 22 2021
Total Return Level Benchmarks
GSK PLC | 289.41 |
Amgen Inc | 427.23 |
Sanofi SA | 106.95 |
Viking Therapeutics Inc | 79.91 |
Fusion Pharmaceuticals Inc | 21.40 |